Oncolys BioPharma Inc. (TYO:4588)
Japan flag Japan · Delayed Price · Currency is JPY
7,410.00
-210.00 (-2.76%)
Nov 18, 2026, 10:45 AM JST

Oncolys BioPharma Market Cap

Oncolys BioPharma has a market cap or net worth of 218.95 billion as of November 17, 2026. It is the 7,945th most valuable company in the world and the 589th biggest in Japan. Its market cap has increased by 712.12% in one year.

Market Cap
218.95B
Enterprise Value
216.19B
Revenue
28.55M
Global Rank
Country Rank
#589 Japan
PE Ratio
n/a

Chart

Chart

Since December 6, 2013, Oncolys BioPharma's market cap has increased from 23.62B to 218.95B, an increase of 827.05%. That is a compound annual growth rate of 18.76%.

History

DateMarket Cap% Change
Nov 16, 2026238.75B503.09%
Dec 30, 202539.59B207.33%
Dec 30, 202412.88B18.41%
Dec 29, 202310.88B19.14%
Dec 30, 20229.13B-0.44%
Dec 30, 20219.17B-58.26%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Nxera Pharma165.14B
GNI Group149.19B
PeptiDream140.01B
Heartseed67.58B
SanBio Company65.10B
Cuorips53.82B
3-D Matrix39.42B
Healios K.K.29.55B
Market Cap Rankings